Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» pandemic
pandemic
AbbVie CEO: Don't worry, Allergan's aesthetics clients still have money—and 'strong desire' for treatment
Fierce Pharma
Fri, 05/1/20 - 12:57 pm
AbbVie
Allergan
M&A
aesthetics
pandemic
COVID-19
Faster Drug Development Processes Likely to Outlive COVID-19
BioSpace
Thu, 04/30/20 - 10:30 pm
drug development
pandemic
COVID-19
AstraZeneca, racing past rivals, throws its weight behind Oxford's COVID-19 vaccine
BioPharma Dive
Thu, 04/30/20 - 10:51 am
AstraZeneca
vaccines
University of Oxford
COVID-19
pandemic
Abiomed stock up amid Street-beating Q4 profits, news of Breethe acquisition
Mass Device
Thu, 04/30/20 - 10:45 am
Abiomed
devices
earnings
M&A
Breethe
ECMO
COVID-19
pandemic
Pear rolls out digital therapy for schizophrenia under FDA’s COVID-19 scheme
Pharmaforum
Thu, 04/30/20 - 10:32 am
Pear Therapeutics
digital therapeutics
schizophrenia
FDA
COVID-19
pandemic
GSK sees 'modest' impact on trials, getting head down for 'busy few months' on COVID-19 work
Fierce Biotech
Thu, 04/30/20 - 10:29 am
GSK
clinical trials
COVID-19
pandemic
Gilead CEO: We’re going to make sure that access is not an issue with remdesivir
Stat
Wed, 04/29/20 - 10:54 pm
Gilead Sciences
Daniel O'Day
Pharma CEOs
remdesivir
COVID-19
pandemic
access
FDA guides generic drugmakers on bioequivalence study disruptions amid COVID-19
RAPS.org
Wed, 04/29/20 - 10:50 pm
FDA
generics
bioequivalence studies
COVID-19
pandemic
AZ maintains 2020 guidance as Q1 sales grow despite pandemic
Pharmaforum
Wed, 04/29/20 - 10:49 am
AstraZeneca
earnings
COVID-19
pandemic
Anthem’s PBM And Medicare Advantage Drive Growth Ahead Of Coronavirus Impact
Forbes
Wed, 04/29/20 - 10:34 am
Anthem
PBMs
Medicare
COVID-19
pandemic
FDA, EU authorities update guidance on clinical trials during COVID-19
RAPS.org
Tue, 04/28/20 - 11:52 pm
FDA
EMA
Europe
clinical trials
COVID-19
pandemic
Quest Diagnostics Is Set to Ride Out Coronavirus Concerns
Motley Fool
Tue, 04/28/20 - 11:50 pm
Quest Diagnostics
COVID-19
pandemic
diagnostics
earnings
COVID-19 to hurt 2020 revenues, says Merck & Co
Pharmaforum
Tue, 04/28/20 - 11:47 pm
Merck
pandemic
COVID-19
Children, Women Just As Likely To Contract COVID-19, But Men Exhibit Worse Symptoms, Study Suggests
Forbes
Tue, 04/28/20 - 11:42 pm
China
COVID-19
pandemic
gender differences
coronaviruses
Merck, slower than its peers, edges into COVID-19 fight
Fierce Biotech
Tue, 04/28/20 - 11:06 am
Merck
earnings
COVID-19
pandemic
R&D
The world wants answers on Gilead’s Covid-19 drug. Experts worry next studies may increase uncertainty
Stat
Tue, 04/28/20 - 11:02 am
Gilead Sciences
remdesivir
COVID-19
pandemic
Is Medtech Prepared for Recovery?
Medical Devices and Diagnostics Industry
Tue, 04/28/20 - 11:09 am
COVID-19
pandemic
Medtech
devices
India pharma manufacturing hub back up and running after COVID-19 lockdown: report
Fierce Pharma
Mon, 04/27/20 - 07:32 pm
Indian
drug manufacturing
COVID-19
pandemic
‘More people will die from pancreatic cancer’: How COVID-19 is diverting resources and costing lives
Pharmaforum
Mon, 04/27/20 - 09:28 am
pandemic
COVID-19
pancreatic cancer
AbbVie, Lilly and Gilead stay on top of pharma ad spending list for March amid steady overall spending
Fierce Pharma
Mon, 04/27/20 - 09:21 am
AbbVie
Eli Lilly
Gilead Sciences
pharma advertising
DTC ads
television ads
pandemic
COVID-19
Pages
« first
‹ previous
…
32
33
34
35
36
37
38
39
40
next ›
last »